← SynDRA
CENTANAFADINE
SynDRA canonical compound SYN0038049 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Primary target(s) | SLC6A2 | SLC6A3 | SLC6A4 |
| Mechanism of action | dopamine reuptake inhibitor |
All known targets
Mechanisms of action (all sources)
- SLC6A4 INHIBITOR
- Monoamine transporter inhibitor
- SLC6A3 INHIBITOR
- SLC6A2 INHIBITOR
- dopamine reuptake inhibitor
Cross-references
Synonyms
- Centanafadina
- DOV 216,419
- DOV 216,419 free base
- DOV-216419
- EB-1020
- EB-1020 free base
- Triple serotonin/dopamine/norepinephrine reuptake inhibitor (depression/pain), Dov
- Triple serotonin/dopamine/norepinephrine reuptake inhibitor (depression/pain), Euthymics
- centanafadina
- UNII-D2A6T4UH9C
- Centanafadine [USAN:INN]
- D2A6T4UH9C
- Centanafadine [USAN]
- CENTANAFADINE [INN]
- CENTANAFADINE, (+)-
- CENTANAFADINE [WHO-DD]
- (1R,5S)-1-(Naphthalen-2-yl)-3-azabicyclo[3.1.0]hexane
- Centanafadine (USAN)
- 3-Azabicyclo(3.1.0)hexane, 1-(2-naphthalenyl)-, (1R,5S)-
- (1R,5S)-1-(naphthalen-2-yl)-3-azabicyclo(3.1.0)hexane
- centanafadinum
- RefChem:124329
- (1R,5S)-1-(2-Naphthyl)-3-azabicyclo[3.1.0]hexane
- MFCD28902249
- (1r,5s)-1-naphthalen-2-yl-3-azabicyclo[3.1.0]hexane
- (1R,5S)-1-(2-Naphthalenyl)-3-azabicyclo[3.1.0]hexane
- Centanafadine (free base)
- Centanafadine (USAN/INN)
- A1EA2
- Centanafadine (EB-1020)
- orb1710091
- SCHEMBL4187417
- SCHEMBL29376902
- HKHCSWPSUSWGLI-CABCVRRESA-N
- AC7288
- AKOS040732783
- DA-72079
- HY-16736
- SY247368
Look up CENTANAFADINE in the interactive SynDRA portal →